The current COVID-19 pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes severe acute respiratory distress in a significant proportion of ...

Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies ...

EXTON, Pa., May 24, 2021 /PRNewswire-PRWeb/ — Megna Health, a U.S. manufacturer of Rapid COVID Tests based in Exton, Pennsylvania, announced that it has filed a U.S. Food and Drug Administration (FDA) ...

The analysis included results from 2 tests that have received EUA: the SARS-CoV-2 ELISA test (Euroimmun) and the COVID-19 IgG/IgM Rapid Test Cassette (Healgen). The Food and Drug Administration (FDA) ...

INCHEON, South Korea--(BUSINESS WIRE)--Celltrion Group (KRX:068270) today announced the launch of two rapid kits for SARS-CoV-2 in the US by the third week of August. SAMPINUTE TM COVID-19 Antigen MIA ...

WASHINGTON -- U.S. regulators are moving ahead with a crackdown on scores of antibody tests for the coronavirus that have not yet been shown to work. The Food and Drug Administration on Thursday ...

The Food and Drug Administration has issued Emergency Use Authorization for Abbott’s AdviseDx SARS-CoV-2 IgM (immunoglobulin M) lab-based serology test for use on the Architect and Alinity platforms.

“For many people, the antibody test gets around the question and key concern, ‘did I have COVID-19 and not know it because I either had mild symptoms for only a few days or didn’t show any symptoms at ...

Assay has 99.9% specificity and 98.3% sensitivity at 15-30 days post-symptom onset and confirmed 95.5% positive predictive value when disease incidence is as low as 3% Beckman Coulter developed ...

INCHEON, South Korea--(BUSINESS WIRE)--Celltrion Group (KRX:068270) today announced the launch of two rapid kits for SARS-CoV-2 in the US by the third week of August. SAMPINUTE TM COVID-19 Antigen MIA ...

HIGH WYCOMBE, England, Nov. 10, 2020 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries ...